3-Hexaprenyl-4,5-Dihydroxybenzoic acid



Compound IDCDAMM02125
Common name3-Hexaprenyl-4,5-Dihydroxybenzoic acid
IUPAC name3-(3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl)-4,5-dihydroxybenzoic acid
Molecular formulaC37H54O4

Experimental data

Retention time7.43
Adduct[M+H]+
Actual mz563.409
Theoretical mz563.409
Error0.31
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.264

Identifiers and class information

Inchi keyVEPICJBQCOUQPI-IRVXXIIISA-N
SmilesO=C(O)C1=CC(O)=C(O)C(=C1)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)10
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)20
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)562.831
Computed dipole moment(dipole)9.199
Total solvent accessible surface area (SASA)1111.19
Hydrophobic component of SASA (FOSA)834.433
Hydrophilic component of SASA (FISA)175.584
Pie component of the SASA (PISA)101.177
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2081.26
Number of hydrogen bond donors (donorHB)3
Number of hydrogen bond acceptors (accptHB)3.5
Free energy of solvation of dipole (dip^2/V)0.0406572
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0054556
Globularity descriptor (glob)0.709458
Predicted polarizability in cubic angstroms (QPpolrz)65.262
Predicted hexadecane/gas partition coefficient (QPlogPC16)21.091
Predicted octanol/gas partition coefficient (QPlogPoct)27.987
Predicted water/gas partition coefficient (QPlogPw)7.706
Predicted octanol/water partition coefficient (QPlogPo/w)9.93
Predicted aqueous solubility (QPlogS)-11.526
Conformation-independent predicted aqueous solubility (CIQPlogS)-9.408
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.908
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)54.255
Predicted brain/blood partition coefficient (QPlogBB)-2.968
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)26.969
Predicted skin permeability, log Kp (QPlogKp)-2.479
PM3 calculated ionization potential (IP(ev))9.318
PM3 calculated electron affinity (EA(eV))0.476
Number of likely metabolic reactions (#metab)20
Prediction of binding to human serum albumin (QPlogKhsa)2.395
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)90.214
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)92.323
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P06746POLBDNA polymerase beta (by homology)T06958SEA
Q14534SQLESqualene monooxygenase (by homology)T93344SEA
P49356FNTBFarnesyl protein transferaseT13127SEA
P12268IMPDH2Inosine-5'-monophosphate dehydrogenase 2T89360SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P49356FNTBFarnesyl protein transferaseT13127SEA
O95749GGPS1GeranyltranstransferaseT86528SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T93344DI0118Dermatophytosis[ICD-11: 1F28]Q14534SQLE
T93344DI0385Skin fungal infection disorder[ICD-11: EA60]Q14534SQLE
T13127DI0342Premature ageing appearance[ICD-11: LD2B]P49356FNTB
T89360DI0413Transplant rejection[ICD-11: NE84]P12268IMPDH2
T13127DI0342Premature ageing appearance[ICD-11: LD2B]P49356FNTB
T86528DI0057Bone paget disease[ICD-11: FB85]O95749GGPS1
T86528DI0237Low bone mass disorder[ICD-11: FB83]O95749GGPS1
T86528DI0267Mineral excesses[ICD-11: 5B91]O95749GGPS1
T86528DI0281Musculoskeletal disorder[ICD-11: FA00-FC0Z]O95749GGPS1

Copyright © 2025